Review





Similar Products

anti mouse pd l1 b7 h1 antibody  (MedChemExpress)
94
MedChemExpress anti mouse pd l1 b7 h1 antibody
Anti Mouse Pd L1 B7 H1 Antibody, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse pd l1 b7 h1 antibody/product/MedChemExpress
Average 94 stars, based on 1 article reviews
anti mouse pd l1 b7 h1 antibody - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
murine pd l1  (Sino Biological)
94
Sino Biological murine pd l1
Murine Pd L1, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/murine pd l1/product/Sino Biological
Average 94 stars, based on 1 article reviews
murine pd l1 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
p99145  (MedChemExpress)
94
MedChemExpress p99145
P99145, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p99145/product/MedChemExpress
Average 94 stars, based on 1 article reviews
p99145 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
anti mouse pd l1 pe  (Thermo Fisher)
94
Thermo Fisher anti mouse pd l1 pe
Anti Mouse Pd L1 Pe, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse pd l1 pe/product/Thermo Fisher
Average 94 stars, based on 1 article reviews
anti mouse pd l1 pe - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
resource source identifier murine pd l1 fc fusion protein sinobiological 50010 m02h lipopolysaccharide lps  (Sino Biological)
94
Sino Biological resource source identifier murine pd l1 fc fusion protein sinobiological 50010 m02h lipopolysaccharide lps
Resource Source Identifier Murine Pd L1 Fc Fusion Protein Sinobiological 50010 M02h Lipopolysaccharide Lps, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/resource source identifier murine pd l1 fc fusion protein sinobiological 50010 m02h lipopolysaccharide lps/product/Sino Biological
Average 94 stars, based on 1 article reviews
resource source identifier murine pd l1 fc fusion protein sinobiological 50010 m02h lipopolysaccharide lps - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
mouse pd l1 his  (Sino Biological)
94
Sino Biological mouse pd l1 his
Mouse Pd L1 His, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse pd l1 his/product/Sino Biological
Average 94 stars, based on 1 article reviews
mouse pd l1 his - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
mouse anti pd l1 antibody  (Proteintech)
96
Proteintech mouse anti pd l1 antibody
Mouse Anti Pd L1 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti pd l1 antibody/product/Proteintech
Average 96 stars, based on 1 article reviews
mouse anti pd l1 antibody - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
anti human mouse pd l1  (Proteintech)
96
Proteintech anti human mouse pd l1
Anti Human Mouse Pd L1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti human mouse pd l1/product/Proteintech
Average 96 stars, based on 1 article reviews
anti human mouse pd l1 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
anti mouse pd l1 antibody  (MedChemExpress)
94
MedChemExpress anti mouse pd l1 antibody
In vivo treatment schedule and therapeutic outcomes. (A) Experimental timeline for control, radiotherapy (IR), <t>anti-PD-L1</t> (ICI), and combination groups. (B) Positioning of tumor-bearing mice for 6 MV x-ray irradiation. (C) Representative image of tumor harvesting on day 7. (D) Tumor-growth curves (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. ∗, ∗∗, ∗∗∗, or ∗∗∗∗ represent p-values <0.05, < 0.01, < 0.001, and <0.0001, respectively. X-axis: Number of days, corresponding to the treatment timeline, with the first day being the first day of treatment. Y-axis: Tumor volume growth, measured as the difference between the tumor volume on the day of measurement and the tumor volume before treatment (first day). (E) Body-weight changes over the study period (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. X-axis: Number of days. Y-axis: Mouse weight, measured as mouse weight on the day of measurement.
Anti Mouse Pd L1 Antibody, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse pd l1 antibody/product/MedChemExpress
Average 94 stars, based on 1 article reviews
anti mouse pd l1 antibody - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
anti mouse pd l1  (MedChemExpress)
94
MedChemExpress anti mouse pd l1
In vivo treatment schedule and therapeutic outcomes. (A) Experimental timeline for control, radiotherapy (IR), <t>anti-PD-L1</t> (ICI), and combination groups. (B) Positioning of tumor-bearing mice for 6 MV x-ray irradiation. (C) Representative image of tumor harvesting on day 7. (D) Tumor-growth curves (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. ∗, ∗∗, ∗∗∗, or ∗∗∗∗ represent p-values <0.05, < 0.01, < 0.001, and <0.0001, respectively. X-axis: Number of days, corresponding to the treatment timeline, with the first day being the first day of treatment. Y-axis: Tumor volume growth, measured as the difference between the tumor volume on the day of measurement and the tumor volume before treatment (first day). (E) Body-weight changes over the study period (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. X-axis: Number of days. Y-axis: Mouse weight, measured as mouse weight on the day of measurement.
Anti Mouse Pd L1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse pd l1/product/MedChemExpress
Average 94 stars, based on 1 article reviews
anti mouse pd l1 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

Image Search Results


In vivo treatment schedule and therapeutic outcomes. (A) Experimental timeline for control, radiotherapy (IR), anti-PD-L1 (ICI), and combination groups. (B) Positioning of tumor-bearing mice for 6 MV x-ray irradiation. (C) Representative image of tumor harvesting on day 7. (D) Tumor-growth curves (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. ∗, ∗∗, ∗∗∗, or ∗∗∗∗ represent p-values <0.05, < 0.01, < 0.001, and <0.0001, respectively. X-axis: Number of days, corresponding to the treatment timeline, with the first day being the first day of treatment. Y-axis: Tumor volume growth, measured as the difference between the tumor volume on the day of measurement and the tumor volume before treatment (first day). (E) Body-weight changes over the study period (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. X-axis: Number of days. Y-axis: Mouse weight, measured as mouse weight on the day of measurement.

Journal: Technology in Cancer Research & Treatment

Article Title: Combining Radiation and anti-PD-L1 Enhances the Antitumor Activity in Colorectal Cancer via IFN-γ-Dependent Activation of STAT1

doi: 10.1177/15330338251406931

Figure Lengend Snippet: In vivo treatment schedule and therapeutic outcomes. (A) Experimental timeline for control, radiotherapy (IR), anti-PD-L1 (ICI), and combination groups. (B) Positioning of tumor-bearing mice for 6 MV x-ray irradiation. (C) Representative image of tumor harvesting on day 7. (D) Tumor-growth curves (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. ∗, ∗∗, ∗∗∗, or ∗∗∗∗ represent p-values <0.05, < 0.01, < 0.001, and <0.0001, respectively. X-axis: Number of days, corresponding to the treatment timeline, with the first day being the first day of treatment. Y-axis: Tumor volume growth, measured as the difference between the tumor volume on the day of measurement and the tumor volume before treatment (first day). (E) Body-weight changes over the study period (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. X-axis: Number of days. Y-axis: Mouse weight, measured as mouse weight on the day of measurement.

Article Snippet: Therapeutic agents: anti-mouse PD-L1 antibody (clone 10F.9G2), recombinant mouse IFN-γ and Itacitinib (both MedChemExpress).

Techniques: In Vivo, Control, Irradiation